A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)
NCT ID: NCT01003886
Last Updated: 2021-01-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
989 participants
OBSERVATIONAL
2009-05-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement
NCT00648323
Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia
NCT00730418
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
NCT00224107
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
NCT00224120
Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH
NCT01966614
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Open Label
Adult male diagnosed with BPH and prescribed with Doxazosin mesylate GITS
Doxazosin mesylate GITS
Doxazosin mesylate GITS 4mg to 8mg once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Doxazosin mesylate GITS
Doxazosin mesylate GITS 4mg to 8mg once daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Butuan, Agusan Del Norte, Philippines
Pfizer Investigational Site
San Juan City, Batangas, Philippines
Pfizer Investigational Site
Tagbilaran City, Bohol, Philippines
Pfizer Investigational Site
Quezon City, Diliman, Philippines
Pfizer Investigational Site
City of San Fernando, La Union, Philippines
Pfizer Investigational Site
Ermita, Manila, Philippines
Pfizer Investigational Site
Tondo, Manila, Philippines
Pfizer Investigational Site
Diliman, Quezon City, National Capital Region, Philippines
Pfizer Investigational Site
Pasig, National Capital Region, Philippines
Pfizer Investigational Site
Angeles City, Pampanga, Philippines
Pfizer Investigational Site
Angeles, , Philippines
Pfizer Investigational Site
Angeles City, , Philippines
Pfizer Investigational Site
Bacolod City, , Philippines
Pfizer Investigational Site
Baguio City, , Philippines
Pfizer Investigational Site
Bohol, , Philippines
Pfizer Investigational Site
Bulacan, , Philippines
Pfizer Investigational Site
Butuan, , Philippines
Pfizer Investigational Site
Cagayan de Oro, , Philippines
Pfizer Investigational Site
Cebu, , Philippines
Pfizer Investigational Site
Cebu City, , Philippines
Pfizer Investigational Site
Cebu City, , Philippines
Pfizer Investigational Site
City of Muntinlupa, , Philippines
Pfizer Investigational Site
Davao City, , Philippines
Pfizer Investigational Site
Gallares City, , Philippines
Pfizer Investigational Site
General Santos, , Philippines
Pfizer Investigational Site
Iligan City, , Philippines
Pfizer Investigational Site
Ilocos Norte, , Philippines
Pfizer Investigational Site
Kalibo, , Philippines
Pfizer Investigational Site
Kalibo Aklan, , Philippines
Pfizer Investigational Site
La Union, , Philippines
Pfizer Investigational Site
Laguna, , Philippines
Pfizer Investigational Site
Laoag, , Philippines
Pfizer Investigational Site
Lingayen, Pangasinan, , Philippines
Pfizer Investigational Site
Makati City, , Philippines
Pfizer Investigational Site
Malabon, , Philippines
Pfizer Investigational Site
Manadaluyong, , Philippines
Pfizer Investigational Site
Mandaluyong, , Philippines
Pfizer Investigational Site
Mandaue City, , Philippines
Pfizer Investigational Site
Manila, , Philippines
Pfizer Investigational Site
Manila, , Philippines
Pfizer Investigational Site
Marikina City, , Philippines
Pfizer Investigational Site
Mindanaw, , Philippines
Pfizer Investigational Site
Nueva Ecija, , Philippines
Pfizer Investigational Site
Nueva Vizcaya, , Philippines
Pfizer Investigational Site
Ozamiz, , Philippines
Pfizer Investigational Site
Pampanga, , Philippines
Pfizer Investigational Site
Pasig, , Philippines
Pfizer Investigational Site
Philippines, , Philippines
Pfizer Investigational Site
Quezon, , Philippines
Pfizer Investigational Site
Quezon City, , Philippines
Pfizer Investigational Site
Quezon City, , Philippines
Pfizer Investigational Site
Quezon City, , Philippines
Pfizer Investigational Site
Quezon City, , Philippines
Pfizer Investigational Site
Rizal, , Philippines
Pfizer Investigational Site
San Jose, , Philippines
Pfizer Investigational Site
Surigao City, , Philippines
Pfizer Investigational Site
Tacloban City, , Philippines
Pfizer Investigational Site
Tagbilaran City, , Philippines
Pfizer Investigational Site
Tagbilaran City, , Philippines
Pfizer Investigational Site
Tagum, , Philippines
Pfizer Investigational Site
Tarlac City, , Philippines
Pfizer Investigational Site
Tarlac City, , Philippines
Pfizer Investigational Site
Tuguegarao City, , Philippines
Pfizer Investigational Site
Valenzuela, , Philippines
Pfizer Investigational Site
Vigan, , Philippines
Pfizer Investigational Site
Visayas, , Philippines
Pfizer Investigational Site
West Fairview, Quezon City, , Philippines
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A0351068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.